Your browser doesn't support javascript.
loading
NMIHBA results from hypomorphic PRUNE1 variants that lack short-chain exopolyphosphatase activity.
Nistala, Harikiran; Dronzek, John; Gonzaga-Jauregui, Claudia; Chim, Shek Man; Rajamani, Saathyaki; Nuwayhid, Samer; Delgado, Dennis; Burke, Elizabeth; Karaca, Ender; Franklin, Matthew C; Sarangapani, Prasad; Podgorski, Michael; Tang, Yajun; Dominguez, Melissa G; Withers, Marjorie; Deckelbaum, Ron A; Scheonherr, Christopher J; Gahl, William A; Malicdan, May C; Zambrowicz, Brian; Gale, Nicholas W; Gibbs, Richard A; Chung, Wendy K; Lupski, James R; Economides, Aris N.
Afiliação
  • Nistala H; Regeneron Genetics Center, Tarrytown, NY 10591, USA.
  • Dronzek J; Regeneron Genetics Center, Tarrytown, NY 10591, USA.
  • Gonzaga-Jauregui C; Regeneron Genetics Center, Tarrytown, NY 10591, USA.
  • Chim SM; Regeneron Genetics Center, Tarrytown, NY 10591, USA.
  • Rajamani S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
  • Nuwayhid S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
  • Delgado D; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
  • Burke E; Undiagnosed Diseases Program Translational Laboratory, NHGRI, National Institutes of Health, Bethesda, MD 20892, USA.
  • Karaca E; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Franklin MC; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Sarangapani P; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
  • Podgorski M; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
  • Tang Y; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
  • Dominguez MG; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
  • Withers M; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
  • Deckelbaum RA; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Scheonherr CJ; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
  • Gahl WA; Regeneron Genetics Center, Tarrytown, NY 10591, USA.
  • Malicdan MC; Undiagnosed Diseases Program Translational Laboratory, NHGRI, National Institutes of Health, Bethesda, MD 20892, USA.
  • Zambrowicz B; Undiagnosed Diseases Program Translational Laboratory, NHGRI, National Institutes of Health, Bethesda, MD 20892, USA.
  • Gale NW; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
  • Gibbs RA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY 10591, USA.
  • Chung WK; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Lupski JR; Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX 77030, USA.
  • Economides AN; Columbia University Medical Center, New York, NY 10032, USA.
Hum Mol Genet ; 29(21): 3516-3531, 2021 01 06.
Article em En | MEDLINE | ID: mdl-33105479
Neurodevelopmental disorder with microcephaly, hypotonia and variable brain anomalies (NMIHBA) is an autosomal recessive neurodevelopmental and neurodegenerative disorder characterized by global developmental delay and severe intellectual disability. Microcephaly, progressive cortical atrophy, cerebellar hypoplasia and delayed myelination are neurological hallmarks in affected individuals. NMIHBA is caused by biallelic variants in PRUNE1 encoding prune exopolyphosphatase 1. We provide in-depth clinical description of two affected siblings harboring compound heterozygous variant alleles, c.383G > A (p.Arg128Gln), c.520G > T (p.Gly174*) in PRUNE1. To gain insights into disease biology, we biochemically characterized missense variants within the conserved N-terminal aspartic acid-histidine-histidine (DHH) motif and provide evidence that they result in the destabilization of protein structure and/or loss of exopolyphosphatase activity. Genetic ablation of Prune1 results in midgestational lethality in mice, associated with perturbations to embryonic growth and vascular development. Our findings suggest that NMIHBA results from hypomorphic variant alleles in humans and underscore the potential key role of PRUNE1 exopolyphoshatase activity in neurodevelopment.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hidrolases Anidrido Ácido / Monoéster Fosfórico Hidrolases / Transtornos do Neurodesenvolvimento / Deficiência Intelectual / Microcefalia / Hipotonia Muscular / Mutação Tipo de estudo: Etiology_studies Limite: Animals / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hidrolases Anidrido Ácido / Monoéster Fosfórico Hidrolases / Transtornos do Neurodesenvolvimento / Deficiência Intelectual / Microcefalia / Hipotonia Muscular / Mutação Tipo de estudo: Etiology_studies Limite: Animals / Child, preschool / Female / Humans / Infant / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article